14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MACK
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Merrimack Pharmaceuticals stock price down 0% on Tuesday
(Updated on Jun 11, 2024)

Buy or Hold candidate since Apr 26, 2024 Gain 2.72% PDF

No changes to the price of Merrimack Pharmaceuticals stock on the last trading day (Tuesday, 11th Jun 2024). During the last trading day the stock fluctuated 0% from a day low at $15.13 to a day high of $15.13. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a narrow and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 4.09% during the next 3 months and, with a 90% probability hold a price between $15.63 and $15.86 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MACK Signals & Forecast

The Merrimack Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $15.13 and $15.04. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 10, 2024, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. The stock had a Golden Star Signal on Friday, April 19, 2024 for the short-term and also have Golden Star Signal for the medium-term dated Friday, September 22, 2023.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star

The stock had a Golden Star Signal on Friday, April 19, 2024 for the short-term and also have Golden Star Signal for the medium-term dated Friday, September 22, 2023.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Buy
Special Signal Notification

Golden Star 12 Months

The stock had a Golden Star Signal on Friday, April 19, 2024 for the short-term and also have Golden Star Signal for the medium-term dated Friday, September 22, 2023.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Merrimack Pharmaceuticals stock

Merrimack Pharmaceuticals finds support from accumulated volume at $15.12 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $14.52 (-4.00%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (MACK) For The Upcoming Trading Day Of Wednesday 12th

For the upcoming trading day on Wednesday, 12th we expect Merrimack Pharmaceuticals to open at $15.13, and during the day (based on 14 day Average True Range), to move between $15.11 and $15.15, which gives a possible trading interval of +/-$0.0172 (+/-0.11%) up or down from last closing price. If Merrimack Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 0.23% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $15.12, some $0.0100 (0.07%) from the current price of $15.13, our system finds the risk reward attractive.

Is Merrimack Pharmaceuticals stock A Buy?

Merrimack Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Merrimack Pharmaceuticals of Wednesday, June 12, 2024

Fair opening price June 12, 2024 Current price
$15.13 ( 0%) $15.13

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MACK

Fibonacci Support & Resistance Levels

Level Price
R3 15.13 -
R2 15.13 -
R1 15.13 -
Price 15.13
S1 15.13 -
S2 15.13 -
S3 15.13 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 15.13
S1 15.12 -0.0661%
S2 15.07 -0.397%
S3 14.73 -2.64%

MACK Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 20, 2024 May 20, 2024 May 20, 2024 $15.10 99.80%
2 May 09, 2024 May 09, 2024 May 17, 2024 $15.10 99.80%
3 Dec 03, 2019 Dec 13, 2019 Dec 23, 2019 $0.500 14.20%
4 Jul 25, 2019 Sep 06, 2019 Sep 05, 2019 $1.50 27.17%
5 Apr 05, 2017 May 30, 2017 May 26, 2017 $8.30 31.97%

FAQ

What is the symbol for Merrimack Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Merrimack Pharmaceuticals is MACK and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Merrimack Pharmaceuticals Stock?
Merrimack Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Merrimack Pharmaceuticals Stock?
Merrimack Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Merrimack Pharmaceuticals Stock.

What's the current price of Merrimack Pharmaceuticals Stock?
As of the end of day on the Jun 11, 2024, the price of an Merrimack Pharmaceuticals (MACK) share was $15.13.

What is the 52-week high and low for Merrimack Pharmaceuticals Stock?
The 52-week high for Merrimack Pharmaceuticals Stock is $15.89 and the 52-week low is $11.53.

What is the market capitalization of Merrimack Pharmaceuticals Stock?
As of the Jun 11, 2024, the market capitalization of Merrimack Pharmaceuticals is 223.748M.

When is the next earnings date for Merrimack Pharmaceuticals?
The upcoming earnings date for Merrimack Pharmaceuticals is Aug 01, 2024.
Click to get the best stock tips daily for free!

About Merrimack Pharmaceuticals

Merrimack Pharmaceuticals Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.... MACK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT